cbdMD Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-26.94	-74.09	-25.95	12.24	-50.43	-0.41	-1.74	-3.36
Depreciation & Amortization	2.93	2.97	2.25	1.9	0.29	0.22	0.07	0.04
Share-Based Compensation	0.34	0.93	2.92	2.04	2.69	0.68	0.21	0.01
Other Operating Activities	15.37	51.22	4.12	-27.21	32.07	-6.06	-0.88	0.4
Operating Cash Flow	-4.3	-14.97	-14.09	-10.66	-15.38	-5.57	-2.33	-2.9
Capital Expenditures	-0.3	-0.69	-0.34	-1.32	-1.2	-0.02	-0.01	-0.13
Acquisitions	0	0	-2	0	-0.92	0	0	0
Change in Investments	1	0	-0.21	-0.25	0	-0.3	0.2	0
Other Investing Activities	-	-	-	-	-0.02	-0.36	-	-
Investing Cash Flow	0.7	-0.69	-2.55	-1.57	-2.13	-0.68	0.19	-0.13
Share Issuance / Repurchase	2.48	0	0	16.77	19.01	10.93	0.83	1.98
Debt Issued / Paid	-0.13	-0.03	-0.15	1.49	-0.76	0	1.62	0.53
Other Financing Activities	-3.67	-4	28.38	4.12	-0.33	-0.67	-0.07	-
Financing Cash Flow	-1.32	-4.04	28.23	22.37	17.92	10.25	2.39	2.51
Net Cash Flow	-4.92	-19.69	11.59	10.13	0.41	4	0.25	-0.51
Free Cash Flow	-4.6	-15.66	-14.44	-11.98	-16.58	-5.6	-2.34	-3.02
Free Cash Flow Margin	-19.04%	-44.22%	-32.45%	-28.61%	-70.08%	-1219.07%	-52.24%	-148.88%
Free Cash Flow Per Share	-2.27	-11.79	-11.82	-12.22	-41.70	-32.53	-23.25	-45.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).